ArticleFrontiers in medicine2025
Binocular visual function impairment is an independent risk factor in axial length growth and myopia progression.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Oculomotor Profiles in Children Wearing Different Myopia Control Lenses: A Real-World Eye Tracking Study.Vision (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: In order to examine the association between binocular visual function (BVF) impairment and myopia progression, as well as its relationship with axial length (AL), spherical equivalent (SE), and axial length to-corneal radius (AL/CR) ratio. Methods: This 9-month longitudinal study involved 949 children [505 males; mean age: 10.96 ± 0.53 years; baseline SE: -0.62 (-1.38, 0.00); baseline AL: 23.80 ± 0.84]. Participants were classified based on the results of three BVF screenings (suppression, simultaneous vision, fusion vision, and stereopsis): those with normal BVF in all screenings were placed in the normal group, those with abnormal BVF in all screenings in the dysfunction group, and the rest in the unstable group. Linear mixed-effects models were used to assess the relationship between BVF status and changes in myopia indicators. Results: In the fully adjusted model, BVF status was significantly associated with rapid progression of AL, demonstrating a clear dose-response relationship. The annualized AL growth rate was 0.184 mm/year in the normal group, 0.226 mm/year in the unstable group, and 0.521 mm/year in the dysfunction group. All pairwise comparisons of the growth rates were statistically significant (normal vs. unstable: β = -0.00346 mm/month; normal vs. dysfunction: β = -0.02810 mm/month; unstable vs. dysfunction: β = -0.02463 mm/month; all Conclusion: BVF impairment is an independent risk factor for rapid AL growth, with a clear dose-response relationship. BVF screening could be integrated into routine eye examinations for school-aged children, allowing for early identification of individuals at high risk for rapid myopia progression. Incorporating BVF management into current myopia control strategies could lead to more effective, personalized interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.